Keith W. Ward

11.1k total citations · 1 hit paper
67 papers, 8.3k citations indexed

About

Keith W. Ward is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Keith W. Ward has authored 67 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 15 papers in Oncology and 13 papers in Pharmacology. Recurrent topics in Keith W. Ward's work include Genomics, phytochemicals, and oxidative stress (13 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Ocular Surface and Contact Lens (10 papers). Keith W. Ward is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (13 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Ocular Surface and Contact Lens (10 papers). Keith W. Ward collaborates with scholars based in United States, France and United Kingdom. Keith W. Ward's co-authors include Brian R. Smith, Daniel F. Veber, Hung‐Yuan Cheng, Stephen R. Johnson, Kenneth D. Kopple, Brian R. Smith, Colin J. Meyer, Jin-Zhong Zhang, Megan E. Cavet and Scott A. Reisman and has published in prestigious journals such as Circulation, The Journal of Immunology and Diabetes.

In The Last Decade

Keith W. Ward

66 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Properties That Influence the Oral Bioavailability of Drug Candidates

2002 6.0k citations Keith W. Ward et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith W. Ward United States	29	3.5k	2.6k	2.4k	952	923	67	8.3k
Stephen R. Johnson United States	24	3.4k 1.0×	2.8k 1.1×	2.6k 1.1×	798 0.8×	870 0.9×	65	7.7k
Hung‐Yuan Cheng United Kingdom	26	3.1k 0.9×	2.6k 1.0×	2.2k 0.9×	746 0.8×	791 0.9×	64	8.3k
Jonathan B. Baell Australia	39	5.1k 1.4×	2.5k 0.9×	2.2k 0.9×	665 0.7×	929 1.0×	177	9.2k
Brian R. Smith United States	38	4.3k 1.2×	2.6k 1.0×	2.2k 0.9×	1.5k 1.5×	994 1.1×	125	10.5k
Giulio Rastelli Italy	36	4.2k 1.2×	2.0k 0.7×	2.1k 0.9×	703 0.7×	851 0.9×	142	7.5k
Paul D. Leeson United Kingdom	42	5.4k 1.5×	3.0k 1.1×	2.8k 1.2×	728 0.8×	879 1.0×	111	10.6k
Stefano Forli United States	37	6.1k 1.7×	2.9k 1.1×	2.6k 1.1×	1.1k 1.1×	963 1.0×	96	10.7k
Thierry Langer Austria	54	5.1k 1.5×	3.0k 1.1×	3.7k 1.6×	618 0.6×	1.4k 1.5×	252	9.9k
Jeremy R. Greenwood United States	27	6.8k 1.9×	2.9k 1.1×	3.2k 1.4×	1.2k 1.3×	1.2k 1.3×	67	12.1k
Gerhard Wolber Germany	42	4.5k 1.3×	1.8k 0.7×	2.7k 1.1×	744 0.8×	1.1k 1.2×	218	8.0k

Countries citing papers authored by Keith W. Ward

Since Specialization

Citations

This map shows the geographic impact of Keith W. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith W. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith W. Ward more than expected).

Fields of papers citing papers by Keith W. Ward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith W. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith W. Ward. The network helps show where Keith W. Ward may publish in the future.

Co-authorship network of co-authors of Keith W. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Keith W. Ward. A scholar is included among the top collaborators of Keith W. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith W. Ward. Keith W. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ward, Keith W.. (2024). Targeting the NRF2 pathway: A promising approach for corneal endothelial dysfunction. Current Opinion in Pharmacology. 74. 102429–102429. 4 indexed citations

Bubb, Kristen J., Cindy Kok, Owen Tang, et al.. (2017). The NRF2 activator DH404 attenuates adverse ventricular remodeling post-myocardial infarction by modifying redox signalling. Free Radical Biology and Medicine. 108. 585–594. 33 indexed citations

Bubb, Kristen J., Cindy Kok, Owen Tang, et al.. (2016). Abstract 15540: NRF2 Upregulation Attenuates Post-Infarct Ventricular Remodeling by Modifying Redox Signalling. Circulation. 134. 1 indexed citations

Liu, Xiaobin, et al.. (2015). The novel triterpenoid RTA 408 protects human retinal pigment epithelial cells against H2O2-induced cell injury via NF-E2-related factor 2 (Nrf2) activation. Redox Biology. 8. 98–109. 66 indexed citations

Alexeev, Vitali, Lawrence H. Lash, Keith W. Ward, et al.. (2014). Radiation Protection of the Gastrointestinal Tract and Growth Inhibition of Prostate Cancer Xenografts by a Single Compound. Molecular Cancer Therapeutics. 13(12). 2968–2977. 11 indexed citations

Li, Bin, Yimu Lai, Joseph S. Janicki, et al.. (2014). Dihydro-CDDO-trifluoroethyl amide suppresses inflammatory responses in macrophages via activation of Nrf2. Biochemical and Biophysical Research Communications. 444(4). 555–561. 19 indexed citations

Ward, Keith W., et al.. (2012). The Use of the African Green Monkey as a Preclinical Model for Ocular Pharmacokinetic Studies. Journal of Ocular Pharmacology and Therapeutics. 28(3). 290–298. 9 indexed citations

Pfeffer, Bruce A., et al.. (2010). Reduced Myocilin Expression in Cultured Monkey Trabecular Meshwork Cells Induced by a Selective Glucocorticoid Receptor Agonist: Comparison with Steroids. Investigative Ophthalmology & Visual Science. 51(1). 437–437. 21 indexed citations

Proksch, Joel W., et al.. (2008). Nonclinical Safety and Pharmacokinetics of Intravitreally Administered Human-Derived Plasmin in Rabbits and Minipigs. Journal of Ocular Pharmacology and Therapeutics. 24(3). 320–332.

10.

Zhang, Jinzhong, Megan E. Cavet, & Keith W. Ward. (2008). Anti-Inflammatory Effects of Besifloxacin, a Novel Fluoroquinolone, in Primary Human Corneal Epithelial Cells. Current Eye Research. 33(11-12). 923–932. 19 indexed citations

11.

Ward, Keith W., et al.. (2007). Nonclinical Pharmacodynamics, Pharmacokinetics, and Safety of BOL-303224-A, a Novel Fluoroquinolone Antimicrobial Agent for Topical Ophthalmic Use. Journal of Ocular Pharmacology and Therapeutics. 23(3). 243–256. 40 indexed citations

12.

Palovich, Michael R., Katherine L. Widdowson, Miriam Burman, et al.. (2006). Comparison of N,N′-diarylsquaramides and N,N′-diarylureas as antagonists of the CXCR2 chemokine receptor. Bioorganic & Medicinal Chemistry Letters. 17(6). 1713–1717. 32 indexed citations

13.

Evans, Christopher A., Larry J. Jolivette, Rakesh Nagilla, & Keith W. Ward. (2006). EXTRAPOLATION OF PRECLINICAL PHARMACOKINETICS AND MOLECULAR FEATURE ANALYSIS OF “DISCOVERY-LIKE” MOLECULES TO PREDICT HUMAN PHARMACOKINETICS. Drug Metabolism and Disposition. 34(7). 1255–1265. 28 indexed citations

14.

Fries, Harvey E., Christopher A. Evans, & Keith W. Ward. (2005). Evaluation of evaporative light-scattering detection for metabolite quantification without authentic analytical standards or radiolabel. Journal of Chromatography B. 819(2). 339–344. 10 indexed citations

15.

Nagilla, Rakesh, et al.. (2005). Investigation of the utility of published in vitro intrinsic clearance data for prediction of in vivo clearance. Journal of Pharmacological and Toxicological Methods. 53(2). 106–116. 26 indexed citations

16.

Evans, Christopher A., Harvey E. Fries, & Keith W. Ward. (2005). In vitro metabolic fate of a novel structural class: Evidence for the formation of a reactive intermediate on a benzothiophene moiety. Chemico-Biological Interactions. 152(1). 25–36. 4 indexed citations

17.

Jin, Qi, Hong Nie, Katherine L. Widdowson, et al.. (2004). Discovery of potent and orally bioavailable N,N′-diarylurea antagonists for the CXCR2 chemokine receptor. Bioorganic & Medicinal Chemistry Letters. 14(17). 4375–4378. 32 indexed citations

18.

Ward, Keith W. & Brian R. Smith. (2004). A COMPREHENSIVE QUANTITATIVE AND QUALITATIVE EVALUATION OF EXTRAPOLATION OF INTRAVENOUS PHARMACOKINETIC PARAMETERS FROM RAT, DOG, AND MONKEY TO HUMANS. I. CLEARANCE. Drug Metabolism and Disposition. 32(6). 603–611. 166 indexed citations

19.

Ward, Keith W. & Leonard M. Azzarano. (2004). Preclinical Pharmacokinetic Properties of the P-Glycoprotein Inhibitor GF120918A (HCl salt of GF120918, 9,10-Dihydro-5-methoxy-9-oxo-N-[4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]phenyl]-4-acridine-carboxamide) in the Mouse, Rat, Dog, and Monkey. Journal of Pharmacology and Experimental Therapeutics. 310(2). 703–709. 53 indexed citations

20.

Ward, Keith W., et al.. (1998). Dysmorphogenic effects of a specific protein kinase C inhibitor during neurulation. Reproductive Toxicology. 12(5). 525–534. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact